RhD Zygosity
GTR Test Accession: Help GTR000521860.5
NYS CLEP
INHERITED DISEASE
Last updated in GTR: 2022-10-25
Last annual review date for the lab: 2023-06-08 Past due LinkOut
At a Glance
Monitoring; Risk Assessment
Rh-null, regulator type
Genes (1): Help
RHD (1p36.11)
Molecular Genetics - Sequence analysis of the entire coding region: RT-qPCR
Not provided
Not provided
Not provided
Ordering Information
Offered by: Help
Versiti Diagnostic Laboratories
View lab's website
View lab's test page
Specimen Source: Help
Who can order: Help
  • Genetic Counselor
  • Health Care Provider
  • Licensed Physician
  • Nurse Practitioner
Test Order Code: Help
CPT codes: Help
**AMA CPT codes notice
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
Test service: Help
Clinical Testing/Confirmation of Mutations Identified Previously
    OrderCode: 4475
Genetic counseling
Result interpretation
Test development: Help
Test developed by laboratory but exempt from FDA oversight (eg. NYS CLEP approved, offered within a hospital or clinic)
Informed consent required: Help
Based on applicable state law
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 1
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 1
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
Sequence analysis of the entire coding region
RT-qPCR
* Instrument: Not provided
Clinical Information
Test purpose: Help
Monitoring; Risk Assessment
Recommended fields not provided:
Technical Information
Test Comments: Help
Hemolytic disease of the newborn (HDN) results from sensitization of the mother’s immune system to foreign antigens present on the red cells of the fetus. Determining the RHD zygosity of the father is valuable for the management of HDN related to anti-D. Zygosity is typically predicted using Rh phenotype. However, … View more
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
Analytical sensitivity is >99% for mutations within the coding sequence and intron/exon borders.
Assay limitations: Help
Rare variant alleles may not be identified by these assays. Testing parental samples by phenotyping and genotyping is recommended in order to identify discrepancies that may lead to false-negative and false-positive results.
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
No
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Category: FDA exercises enforcement discretion
NYS CLEP Approval: Help
Number: 64860
Status: Approved
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.